Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A follow-up case-control association study of tractable (druggable) genes in recurrent major depression.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics - 1 Sept 2011

Schosser A, Gaysina D, Cohen-Woods S, Domenici E, Perry J, Tozzi F, Korszun A, Gunasinghe C, Gray J, Jones L, Binder E B, Holsboer F, Craddock N, Owen M J, Craig I W, Farmer A E, Muglia P, McGuffin P

Abstract excerpt

The High-Throughput Disease-specific target Identification Program (HiTDIP) aimed to study case-control association samples for 18 common diseases. Here we present the results of a follow-up case-control association study of HiTDIP in major depressive disorder (MDD). The HiTDIP in MDD was conducted in a sample of 974 cases of recurrent MDD of white German origin collected at the Max-Planck Institute (MP-GSK) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Depressive Disorder, Major

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Germany

Share to High-Throughput Screening Assays

Share to Nitric Oxide Synthase Type II

Share to Recurrence

Share to United Kingdom

Source

Identifiers

PMID: 21630437
DOI: 10.1002/ajmg.b.31204

Genes

DPP4
DRD3
ZNF80

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A follow-up case-control association study of tractable (druggable) genes in recurrent major depression.PMID 21630437Read ↗

Genetically informed drug target prioritisation and repurposing for major depressive disorderSemantic proximity Read ↗

Genetic Landscape of Major Depressive Disorder: Assessment of Potential Diagnostic and Antidepressant Response MarkersSemantic proximity Read ↗

Genome survey for susceptibility loci for recurrent, early-onset major depression: results at 10cM resolution.Semantic proximity Read ↗

Genome-wide association study of major recurrent depression in the U.K. population.Semantic proximity Read ↗

Exome-wide screening identifies novel rare risk variants for major depression disorder.Semantic proximity Read ↗

Transcriptome-wide association study of treatment-resistant depression and depression subtypes for drug repurposingSemantic proximity Read ↗

Genome-wide association studies on Northern Italy isolated populations provide further support concerning genetic susceptibility for major depressive disorder.Semantic proximity Read ↗

The successful search for genetic loci associated with depression.Semantic proximity Read ↗

Genetic polymorphism involved in major depressive disorder: a systemic review and meta-analysis.Semantic proximity Read ↗

Genome-wide association study of recurrent early-onset major depressive disorder.Semantic proximity Read ↗

Secondary analysis of GenRED data (Genetics of Recurrent Early-Onset major Depression) using MERLIN.Semantic proximity Read ↗

An Analysis of Two Genome-wide Association Meta-analyses Identifies a New Locus for Broad Depression Phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.